
VNDA EPS Estimates
Vanda Pharmaceuticals Inc.
$4.08
-$0.01(-0.24%)
37
Overall
60
Value
18
Tech
34
Quality
Market Cap
$246.72M
Volume
1.38M
52W Range
$3.57 - $9.94
Target Price
$11.50
VNDA EPS estimates: the consensus estimate for Vanda Pharmaceuticals Inc.'s current fiscal year is -$2.53 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
VNDA EPS Estimates
- EPS estimate, current quarter
- $-0.32
- EPS estimate, next quarter
- $-0.29
- EPS estimate, current year
- $-2.53
- EPS estimate, next year
- $-0.94
- EPS growth, 3-year
- -100.00%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.74 |
| 2024 | $-0.33 |
| 2023 | $0.04 |
| 2022 | $0.11 |
| 2021 | $0.60 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VNDA | $4.08 | -0.2% | 1.38M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Vanda Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW